Published in Nat Genet on December 01, 1999
Lysosomal cysteine proteases: facts and opportunities. EMBO J (2001) 3.06
Specialized roles for cysteine cathepsins in health and disease. J Clin Invest (2010) 2.69
Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A (2002) 2.54
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev (2010) 1.97
MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone (2004) 1.79
Haim-Munk syndrome and Papillon-Lefèvre syndrome are allelic mutations in cathepsin C. J Med Genet (2000) 1.78
Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol (2005) 1.55
Localisation of a gene for prepubertal periodontitis to chromosome 11q14 and identification of a cathepsin C gene mutation. J Med Genet (2000) 1.50
Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. J Cell Biol (2007) 1.22
Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun (2006) 1.17
ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematol Oncol Clin North Am (2012) 1.14
Importance of lysosomal cysteine proteases in lung disease. Respir Res (2000) 1.13
Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol (2007) 1.12
Evidence of a founder effect for four cathepsin C gene mutations in Papillon-Lefèvre syndrome patients. J Med Genet (2001) 1.11
Identification of cathepsin C mutations in ethnically diverse papillon-Lefèvre syndrome patients. J Med Genet (2000) 1.05
Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses. J Clin Invest (2014) 1.03
Identification of a locus for type I punctate palmoplantar keratoderma on chromosome 15q22-q24. J Med Genet (2003) 1.01
Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice. Biol Chem (2006) 0.99
Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. Pharmacol Ther (2011) 0.98
Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion. Am J Hum Genet (2011) 0.98
Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis. J Cell Biol (2007) 0.97
Mutation analysis of the cathepsin C gene in Indian families with Papillon-Lefèvre syndrome. BMC Med Genet (2003) 0.94
Paths of glorious proteases. Nat Genet (1999) 0.93
Eponym: Papillon-Lefevre syndrome. Eur J Pediatr (2010) 0.91
Differential cerebral cortex transcriptomes of baboon neonates consuming moderate and high docosahexaenoic acid formulas. PLoS One (2007) 0.91
Mendelian diseases and conditions in Croatian island populations: historic records and new insights. Croat Med J (2006) 0.91
Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation. Am J Pathol (2002) 0.90
Increased matriptase zymogen activation in inflammatory skin disorders. Am J Physiol Cell Physiol (2010) 0.89
Cathepsin G: roles in antigen presentation and beyond. Mol Immunol (2009) 0.89
DPPI may activate KLK4 during enamel formation. J Dent Res (2009) 0.89
Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity. Front Immunol (2014) 0.88
Free-thiol Cys331 exposed during activation process is critical for native tetramer structure of cathepsin C (dipeptidyl peptidase I). Protein Sci (2002) 0.85
Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes. Diabetes (2015) 0.85
CTSC and Papillon-Lefèvre syndrome: detection of recurrent mutations in Hungarian patients, a review of published variants and database update. Mol Genet Genomic Med (2014) 0.84
Lack of cathelicidin processing in Papillon-Lefèvre syndrome patients reveals essential role of LL-37 in periodontal homeostasis. Orphanet J Rare Dis (2014) 0.84
Identification of novel mutation in cathepsin C gene causing Papillon-Lefèvre Syndrome in Mexican patients. BMC Med Genet (2013) 0.84
Computational identification of uncharacterized cruzain binding sites. PLoS Negl Trop Dis (2010) 0.83
The genetic and molecular bases of monogenic disorders affecting proteolytic systems. J Med Genet (2005) 0.83
Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles. J Biol Chem (2015) 0.83
Genetic mapping in papillon-lefèvre syndrome: a report of two cases. Case Rep Dent (2013) 0.83
Papillon-Lefevre syndrome: Reporting consanguinity as a risk factor. Saudi Dent J (2014) 0.82
Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis). Semin Immunopathol (2013) 0.82
Evidence for a founder mutation in the cathepsin C gene in three families with Papillon-Lefèvre syndrome. Dermatology (2009) 0.82
Papillon-Lefèvre syndrome: Case report and review of the literature. J Indian Soc Periodontol (2012) 0.81
A novel mutation in the cathepsin C gene in a Pakistani family with Papillon-Lefevre syndrome. J Eur Acad Dermatol Venereol (2010) 0.81
Papillon-Lefevre syndrome: A case report of 2 affected siblings. J Indian Soc Periodontol (2013) 0.80
Renal abscess in Papillion-Lefèvre syndrome. Pediatr Surg Int (2011) 0.80
Papillon-Lefèvre syndrome: clinical presentation and management options. Clin Cosmet Investig Dent (2015) 0.79
Cell cycle- and cancer-associated gene networks activated by Dsg2: evidence of cystatin a deregulation and a potential role in cell-cell adhesion. PLoS One (2015) 0.79
Papillon- Lefèvre Syndrome: Report of a case and its management. J Clin Exp Dent (2012) 0.79
On putative periodontal pathogens: an epidemiological perspective. Virulence (2015) 0.78
Cytokine production by leukocytes of Papillon-Lefèvre syndrome patients in whole blood cultures. Clin Oral Investig (2011) 0.78
Proteases, neutrophils, and periodontitis: the NET effect. J Clin Invest (2014) 0.78
Lysosomal protease expression in mature enamel. Cells Tissues Organs (2008) 0.77
Genetic dissection of NK cell responses. Front Immunol (2013) 0.77
Effect of gene polymorphisms on periodontal diseases. Indian J Hum Genet (2012) 0.77
Science is the fuel for the engine of technology and clinical practice. J Am Dent Assoc (2009) 0.77
Novel cathepsin C mutation in a Brazilian family with Papillon-Lefèvre syndrome: case report and mutation update. J Dent Child (Chic) (2010) 0.76
Congenital defects in neutrophil dynamics. J Immunol Res (2014) 0.76
Animal models of human granulocyte diseases. Hematol Oncol Clin North Am (2012) 0.76
Palmoplantar keratoderma with dental abnormalities. Indian Dermatol Online J (2014) 0.75
Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases. J Biol Chem (2016) 0.75
Whole-exome sequencing reveals a recurrent mutation in the cathepsin C gene that causes Papillon-Lefevre syndrome in a Saudi family. Saudi J Biol Sci (2015) 0.75
Papillon-Lefevre Syndrome In An Adolescent Female: A Case Study. J Clin Diagn Res (2015) 0.75
Primary immunodeficiencies associated with eosinophilia. Allergy Asthma Clin Immunol (2016) 0.75
Papillon-Lefèvre syndrome and squamous cell carcinoma: a case report. Cases J (2009) 0.75
Papillon-Lefèvre syndrome: a series of five cases among siblings. J Med Case Rep (2016) 0.75
Low expression of angiotensinogen and dipeptidyl peptidase 1 in saliva of patients with proliferative verrucous leukoplakia. World J Clin Cases (2016) 0.75
Identification, immunolocalization, and characterization analyses of an exopeptidase of papain superfamily, (cathepsin C) from Clonorchis sinensis. Parasitol Res (2014) 0.75
Epithelial desquamation observed in a Phase I study of an oral cathepsin C inhibitor (GSK2793660). Br J Clin Pharmacol (2017) 0.75
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
Smoking and mental illness: A population-based prevalence study. JAMA (2000) 14.17
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
The rapid formation of a large rotating disk galaxy three billion years after the Big Bang. Nature (2006) 6.44
Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (1991) 6.15
Gene Ontology annotations and resources. Nucleic Acids Res (2012) 6.13
On a Back Cross in Mice Involving Three Allelomorphic Pairs of Characters. Genetics (1918) 6.12
A family of human cdc2-related protein kinases. EMBO J (1992) 4.96
Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol (2001) 4.94
Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell (1999) 4.87
Progress towards construction of a total restriction fragment map of a human chromosome. Nucleic Acids Res (1987) 4.68
Incidence and preventability of adverse drug events in nursing homes. Am J Med (2000) 4.33
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14
Situs inversus and embryonic ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II. Proc Natl Acad Sci U S A (1999) 4.11
Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02
Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med (1981) 3.98
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet (2009) 3.87
SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet (1998) 3.82
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest (1998) 3.66
Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature (1992) 3.63
Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol (1998) 3.51
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45
Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med (1995) 3.25
Prevalence of child physical and sexual abuse in the community. Results from the Ontario Health Supplement. JAMA (1997) 3.24
Disclosure of authors' conflicts of interest: a follow-up. N Engl J Med (2000) 3.16
Risk factors for adverse drug events among nursing home residents. Arch Intern Med (2001) 3.12
Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet (1994) 2.99
Education, age, and the cumulative advantage in health. J Health Soc Behav (1996) 2.93
Racial differences in the response to drugs--pointers to genetic differences. N Engl J Med (2001) 2.90
Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol (2001) 2.86
Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther (1979) 2.85
Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy. Br J Anaesth (2009) 2.83
Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron (2000) 2.82
The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med (2001) 2.74
Municipal waterborne giardiasis: an epidemilogic investigation. Beavers implicated as a possible reservoir. Ann Intern Med (1980) 2.69
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68
Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature (2002) 2.59
Use of drugs by children. BMJ (1988) 2.55
The genetics of hand malformations. Birth Defects Orig Artic Ser (1978) 2.55
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51
Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein. Br J Obstet Gynaecol (1980) 2.50
Survival in frontotemporal dementia. Neurology (2003) 2.48
The Dehydrogenation of Alcohols by Streptococci of Group B. J Bacteriol (1942) 2.46
The second locus for autosomal recessive primary microcephaly (MCPH2) maps to chromosome 19q13.1-13.2. Eur J Hum Genet (2000) 2.31
The 5'-proximal region of the wheat Cab-1 gene contains a 268-bp enhancer-like sequence for phytochrome response. EMBO J (1987) 2.31
Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling. Clin Pharmacol Ther (1979) 2.31
Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol (1973) 2.31
Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med (1989) 2.29
How often is genital yeast infection sexually transmitted? Br Med J (1977) 2.28
Local research ethics committee approval for a national study in Scotland. J R Coll Surg Edinb (1998) 2.28
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res (1999) 2.24
Consanguinity and complex cardiac anomalies with situs ambiguus. Arch Dis Child (1984) 2.21
One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry (1996) 2.18
Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction. JAMA (1995) 2.18
Mutation of the gene encoding the enamel-specific protein, enamelin, causes autosomal-dominant amelogenesis imperfecta. Hum Mol Genet (2001) 2.18
The nuclear location signal. Proc R Soc Lond B Biol Sci (1985) 2.14
Hirayama disease: MR diagnosis. AJNR Am J Neuroradiol (1998) 2.14
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology (2003) 2.14
Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology (2000) 2.09
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst (1993) 2.07
Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiation. Int J Radiat Oncol Biol Phys (1993) 2.05
Perioperative corticosteroid supplementation and dento-alveolar surgery. Dent Update (2003) 2.02
A new method for autozygosity mapping using single nucleotide polymorphisms (SNPs) and EXCLUDEAR. J Med Genet (2004) 2.02
Primary autosomal recessive microcephaly (MCPH1) maps to chromosome 8p22-pter. Am J Hum Genet (1998) 2.00
Countercurrent immunoelectrophoresis of urine as well as of CSF and blood for diagnosis of bacterial meningitis. J Pediatr (1976) 2.00
Change in cartilage morphometry: a sample of the progression cohort of the Osteoarthritis Initiative. Ann Rheum Dis (2008) 1.98
Connexin-26 mutations in sporadic non-syndromal sensorineural deafness. Lancet (1998) 1.97
Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest (1972) 1.93
Fractional utilization of the aerobic capacity during distance running. Med Sci Sports (1973) 1.93
PAX genes. Curr Opin Genet Dev (1994) 1.92
Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet (1999) 1.92
Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst (2000) 1.92
Guidelines for DNA banking. Report of the Clinical Genetics Society working party on DNA banking. J Med Genet (1989) 1.91
A third novel locus for primary autosomal recessive microcephaly maps to chromosome 9q34. Am J Hum Genet (2000) 1.91
Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet (1975) 1.91
Extending the scope of the VATER association: definition of the VATER syndrome. J Pediatr (1974) 1.89
Levobupivacaine: a review of its pharmacology and use as a local anaesthetic. Drugs (2000) 1.89
Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. Circulation (1981) 1.88
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos (2000) 1.87
A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. Br J Clin Pharmacol (1976) 1.87
Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome. Am J Hum Genet (2006) 1.85
Stabilisation splint therapy for temporomandibular pain dysfunction syndrome. Cochrane Database Syst Rev (2004) 1.85
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J Cell Sci (1996) 1.84
Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet (2001) 1.84
Clopidogrel. Drugs (1997) 1.83
PUMA- and Bax-induced autophagy contributes to apoptosis. Cell Death Differ (2009) 1.83
Inhibition of FEN-1 processing by DNA secondary structure at trinucleotide repeats. Mol Cell (1999) 1.83
On the DNA content and ploidy of trypanosomes. Mol Biochem Parasitol (1982) 1.82
Phytochrome activation of two nuclear genes requires cytoplasmic protein synthesis. EMBO J (1989) 1.81
Biochemical-physiological correlations in studies of the gamma-aminobutyric acid system. Brain Res (1968) 1.80